Definitive Healthcare (DH)
Combines healthcare data and workflow tools for commercial teams.
Something off on this page? Send us feedback.
Subscriptions combine provider, claims, expert, and workflow data for life-sciences, provider, and diversified customers. Products support healthcare research, targeting, affiliations, claims analysis, and sales execution.
Subscriptions bring together healthcare organization, professional, claims, affiliation, and scientific-expert data with workflow tools for customers selling into or operating across healthcare. Customers include life-sciences companies, care providers, and diversified organizations such as healthcare IT and staffing firms.
Reference & Affiliations: View supplies organization, professional, claims, and affiliation intelligence. Medical & Scientific Experts: Monocl focuses on experts, while Claims & Consumer Analytics: Populi supports physician relationships, network leakage, and market-share work. Sales Enablement: Carevoyance serves MedTech targeting, prospect research, and sales-report automation.
The platform is sold by subscription across those customer markets and depends on maintaining integrated data and workflow capabilities.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Aug 12, 2026 | Deutsche Bank | Reiterate | Rating: —Target: $5 | Target: $1 |
| Aug 11, 2026 | Morgan Stanley | Reiterate | Rating: —Target: $3.50 | Target: $1.50 |
| Jun 29, 2026 | Bank of America Securities | Downgrade | Rating: — | |
| Jun 29, 2026 | B of A Securities | Downgrade | ||
| May 8, 2026 | Robert W. Baird | Target | Target: $4 | Target: $1.10 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $183.6M · Total debt $167.1M · Total assets $496.8M · Shareholders' equity $144.7M
- Revenue
- $55.2M
- Operating income
- −$6.7M
- Net income
- −$5.4M
No dividends on record.
| Institutions | 82.33% | 86.88M shares | |
|---|---|---|---|
| 100 holders · as of Jun 30, 2026 | |||
| Insiders | 30.97% | 32.68M shares | |
| 13 holders · as of Sep 16, 2026 | |||
| Strategic holders | 38.47% | 40.59M shares | |
| 1 holder · as of Dec 31, 2021 | |||
| Adds to | 151.77% | ||
105.52M company shares as of Aug 28, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 151.77%; nothing is left for Other.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Advent International Corp/MAInstitution | 59.22% | 62.49M | as of Jun 30, 2026 |
SEA VII Management, LLC1,2Strategicdirector | 38.47% | 26.75M · 13.84M | filed Dec 31, 2021 |
Jason Ronald Krantz3Insiderdirector, 10 percent owner, other: EXECUTIVE CHAIRMAN | 22.45% | 22.50M · 1.19M | filed Sep 2, 2026 |
Goldman Sachs Group IncInstitution | 5.65% | 5.96M | as of Jun 30, 2026 |
Conestoga Capital Advisors, LLC.Institution | 5.52% | 5.82M | filed Jan 5, 2024 |
- SEA VII Management, LLC's transaction reports restate only vehicles that traded; the 2022 ownership statement (26.75M) is used instead.
- SEA VII Management, LLC reports a block also reported by Dimensional Fund Advisors LP; it is counted once, under Dimensional Fund Advisors LP.
- Jason Ronald Krantz's transaction reports restate only vehicles that traded; the 2026 ownership statement (22.50M) is used instead.
Insider tradesForm 4
No open-market trades in the last 12 months.
- IQVIA
Healthcare data and commercial analytics for life sciences
- Clarivate
Provider, claims, and commercial analytics for MedTech
- Veeva Systems
Life-sciences HCP, KOL, and commercial data workflows
- ZoomInfo
B2B data, intent signals, and sales-automation workflows
- Microsoft
LinkedIn Sales Navigator for B2B prospecting and account research
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Definitive Healthcare | $0.8961 | +0.69% | $93.9M | — | 5.2 | 0.4 | −9.1% |
| IQVIA | $270.29 | +0.07% | $44.46B | 33.5 | 19.9 | 2.6 | +8.7% |
| Clarivate | $1.91 | +1.06% | $1.21B | — | 2.6 | 0.5 | −5.5% |
| Veeva Systems | $270.33 | +3.61% | $42.38B | 42.9 | 28.0 | 12.3 | +17.6% |
| ZoomInfo | $3.92 | +0.90% | $1.14B | — | 3.5 | 0.9 | +1.2% |
| Microsoft | $498.75 | +0.15% | $3.70T | 27.7 | 25.4 | 11.1 | +17.8% |
| Median | 33.5 | 19.9 | 2.6 | +8.7% |